<DOC>
	<DOCNO>NCT01648556</DOCNO>
	<brief_summary>It multicentric study prospective patient ' 60 year thrombopenia isolate less 100 G/L blood platelet without cause find estimate certain examination realize diagnosis ( medullary cytogenetics , dosage TPO , Anti-platelet antibody , isotopic lifetime platelet ) favour diagnosis PTI .</brief_summary>
	<brief_title>Research Predictive Factors Immune Thrombopenic Purpura</brief_title>
	<detailed_description>It multicentric study prospective patient ' 60 year thrombopenia isolate less 100 G/L blood platelet without cause find estimate certain examination realize diagnosis ( medullary cytogenetics , dosage TPO , Anti-platelet antibody , isotopic lifetime platelet ) favour diagnosis PTI . The principal endpoint evaluate medullary cytogenetics predictive factor diagnosis PTI front thrombopenia isolate elderly . The secondary endpoint : - identify time diagnosis , factor and/or predictive marker correlate final diagnosis PTI SMD - study respective frequency PTI SMD front thrombopenia seemingly isolate subject 60 year . 200 patient include . 160 patient assessable end study consider exclude patient , dead lose sight.They follow every 4 month , two year . In every visit , realize clinical examination , blood film , haemogram . If haemogram abnormal , bone marrow biopsy realize . The patient present myelodysplastic syndrome exclude .</detailed_description>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Rate platelet &lt; 100 G/l less 12 month , age = ou &gt; 60 year , haemoglobin &gt; ou = 12 g / dl woman , &gt; ou = 13 g/dl man , polymorphonuclear neutrophil &gt; ou = 1.7 G/l , monocytes &lt; ou= 1 G/l , lymphocytes &lt; ou = Ã  4 G/l , VGM &lt; 100 fL , blood film normal , informed consent , expectation life &gt; 6 month hepatomegaly , splenomegaly , hepatic abnormality , blood coagulation abnormality , antecedent autoimmune disease , drug thrombopenia , HIV , VHB VHC positive , antecedent malicious tumor 5 year inclusion</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Purpura thrombopenic</keyword>
	<keyword>Medullary cytogenetics</keyword>
	<keyword>Myelodysplasic syndrome</keyword>
	<keyword>bone marrow biopsy</keyword>
</DOC>